Psoriasis Trial, Recruiting (NCT05883371)

Psoriasis Trial, Recruiting NCT05883371 Sponsor: AndHealth Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT05883371 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 70 years old
You can read and write in English
You are willing to give your consent and understand what the study involves, including any possible risks
You have been diagnosed with rheumatoid arthritis, psoriatic arthritis, psoriasis, or ankylosing spondylitis, and are currently using or have been recommended a biologic or DMARD medication to treat it

Who may not be able to join:

You are pregnant, breastfeeding, or planning to become pregnant within the next 12 months
You have serious liver or kidney disease
You have previously had an organ transplant or are waiting for one
You are currently receiving treatment for cancer
You have a mental illness that is not well controlled, such as schizophrenia, bipolar disorder, or an active eating disorder
You have a terminal illness
You are currently using opioid medications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Myles Spar, MD, AndHealth

Phone: 614-697-3296

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05883371

Sponsor: AndHealth

Phase: Not Applicable

Status: Recruiting

Condition: Psoriasis

Trial contact: 614-697-3296

More information: https://clinicaltrials.gov/study/NCT05883371

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 70 years old
You can read and write in English
You are willing to give your consent and understand what the study involves, including any possible risks
You have been diagnosed with rheumatoid arthritis, psoriatic arthritis, psoriasis, or ankylosing spondylitis, and are currently using or have been recommended a biologic or DMARD medication to treat it

Who may not be able to join:

You are pregnant, breastfeeding, or planning to become pregnant within the next 12 months
You have serious liver or kidney disease
You have previously had an organ transplant or are waiting for one
You are currently receiving treatment for cancer
You have a mental illness that is not well controlled, such as schizophrenia, bipolar disorder, or an active eating disorder
You have a terminal illness
You are currently using opioid medications

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AndHealth

Registry

ClinicalTrials.gov

Start date

8 June 2023

Est. completion

22 November 2023

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PROMIS - Global Health; Routine Assessment of Patient Index Data 3 (RAPID 3); Dermatology Life Quality Index (DLQI); Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov